As weight-loss drugs like semaglutide and tirzepatide dominate global headlines, a new nationwide survey shows that 87 per ...

The drug is now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Weight-loss jabs will be made available to the poorest who have the highest need, the Government has said in the NHS 10-year ...

A 68-week phase 3 trial found that coadministered cagrilintide and semaglutide led to significant and clinically meaningful ...

The incidence of obesity and diabetes is rising in India, the world’s most populous country, which also ranks among the worst ...

Weight loss injections promise quick results, but skipping blood screening can trigger serious risks like pancreatitis or dehydration—especially in those with hidden health issues.

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management ...

Over 100 cases of acute pancreatitis have been reported to UK health regulators this year, many tied to the newest GLP-1 drug ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

Researchers have found in phase IIIa REDEFINE 1 trial that Addition of investigational cagrilintide to GLP-1 agonist ...

GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan ...